Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
LMX1B
Introduction
LIM homeobox transcription factor 1-beta, also known as LMX1B, is a protein which in humans is encoded by the LMX1B gene.[1][2]
Function
Function
LMX1B is a LIM homeobox transcription factor which plays a central role in dorso-ventral patterning of the vertebrate limb.[3]
Clinical significance
Clinical significance
Mutations in the LMX1B gene are associated with the Nail-patella syndrome.[4]
References
References
- ↑ “Entrez Gene: LMX1B LIM homeobox transcription factor 1, beta”.
- ↑ Iannotti CA, Inoue H, Bernal E, Aoki M, Liu L, Donis-Keller H, German MS, Permutt MA (December 1997). “Identification of a human LMX1 (LMX1.1)-related gene, LMX1.2: tissue-specific expression and linkage mapping on chromosome 9”. Genomics. 46 (3): 520–4. doi:10.1006/geno.1997.5075. PMID 9441763.
- ↑ Schweizer H, Johnson RL, Brand-Saberi B (April 2004). “Characterization of migration behavior of myogenic precursor cells in the limb bud with respect to Lmx1b expression”. Anat. Embryol. 208 (1): 7–18. doi:10.1007/s00429-003-0373-y. PMID 15007643.
- ↑ Dreyer SD, Zhou G, Baldini A, Winterpacht A, Zabel B, Cole W, Johnson RL, Lee B (May 1998). “Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome”. Nat. Genet. 19 (1): 47–50. doi:10.1038/ng0598-47. PMID 9590287.
Further reading
Further reading
- Millá E, Hernan I, Gamundi MJ, et al. (2007). “Novel LMX1B mutation in familial nail-patella syndrome with variable expression of open angle glaucoma”. Mol. Vis. 13: 639–48. PMC 2669506. PMID 17515884.
- Oshimo T, Fukai K, Higashi N, et al. (2008). “A novel LMX1B nonsense mutation in a family with nail-patella syndrome”. J. Dermatol. Sci. 52 (1): 57–60. doi:10.1016/j.jdermsci.2008.04.014. PMID 18562181.
- Ham JH, Shin SJ, Joo KR, et al. (2009). “A synonymous genetic alteration of LMX1B in a family with nail-patella syndrome”. The Korean Journal of Internal Medicine. 24 (3): 274–8. doi:10.3904/kjim.2009.24.3.274. PMC 2732789. PMID 19721866.
- Prichard ZM, Jorm AF, Mackinnon A, Easteal S (2007). “Association analysis of 15 polymorphisms within 10 candidate genes for antisocial behavioural traits”. Psychiatr. Genet. 17 (5): 299–303. doi:10.1097/YPG.0b013e32816ebc9e. PMID 17728669.
- Dunston JA, Lin S, Park JW, et al. (2005). “Phenotype severity and genetic variation at the disease locus: an investigation of nail dysplasia in the nail patella syndrome”. Ann. Hum. Genet. 69 (Pt 1): 1–8. doi:10.1046/j.1529-8817.2004.00133.x. PMID 15638822.
- Bongers EM, de Wijs IJ, Marcelis C, et al. (2008). “Identification of entire LMX1B gene deletions in nail patella syndrome: evidence for haploinsufficiency as the main pathogenic mechanism underlying dominant inheritance in man”. Eur. J. Hum. Genet. 16 (10): 1240–4. doi:10.1038/ejhg.2008.83. PMID 18414507.
- Morello R, Lee B (2002). “Insight into podocyte differentiation from the study of human genetic disease: nail-patella syndrome and transcriptional regulation in podocytes”. Pediatr. Res. 51 (5): 551–8. doi:10.1203/00006450-200205000-00002. PMID 11978876.
- Zarzecki M, Nieszporek T, Chudek J, Wiecek A (2006). “[The nail-patella syndrome: rare genetically determined cause of proteinuria]”. Pol. Arch. Med. Wewn. 116 (6): 1192–9. PMID 18634531.
- Rascle A, Neumann T, Raschta AS, et al. (2009). “The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes”. Exp. Cell Res. 315 (1): 76–96. doi:10.1016/j.yexcr.2008.10.012. PMID 18996370.
- Lin Y, Zhao J, Chen S, et al. (2008). “A novel mutation in LMX1B gene causes nail-patella syndrome in a large Chinese family”. Bone. 43 (3): 591–5. doi:10.1016/j.bone.2008.04.025. PMID 18595794.
- Heidet L, Bongers EM, Sich M, et al. (2003). “In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys”. Am. J. Pathol. 163 (1): 145–55. doi:10.1016/S0002-9440(10)63638-3. PMC 1868155. PMID 12819019.
- Bergman O, HÃkansson A, Westberg L, et al. (2009). “Do polymorphisms in transcription factors LMX1A and LMX1B influence the risk for Parkinson’s disease?”. J Neural Transm. 116 (3): 333–8. doi:10.1007/s00702-009-0187-z. PMID 19189040.
- Park S, Jamshidi Y, Vaideanu D, et al. (2009). “Genetic risk for primary open-angle glaucoma determined by LMX1B haplotypes”. Invest. Ophthalmol. Vis. Sci. 50 (4): 1522–30. doi:10.1167/iovs.08-2483. PMID 18952915.
- Harendza S, Stahl RA, Schneider A (2009). “The transcriptional regulation of podocin (NPHS2) by Lmx1b and a promoter single nucleotide polymorphism”. Cell. Mol. Biol. Lett. 14 (4): 679–91. doi:10.2478/s11658-009-0026-0. PMID 19562271.
- Mishima Y, Lindgren AG, Chizhikov VV, et al. (2009). “Overlapping function of Lmx1a and Lmx1b in anterior hindbrain roof plate formation and cerebellar growth”. J. Neurosci. 29 (36): 11377–84. doi:10.1523/JNEUROSCI.0969-09.2009. PMC 2765661. PMID 19741143.
- Bongers EM, Huysmans FT, Levtchenko E, et al. (2005). “Genotype-phenotype studies in nail-patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathy”. Eur. J. Hum. Genet. 13 (8): 935–46. doi:10.1038/sj.ejhg.5201446. PMID 15928687.
- Fuchs J, Mueller JC, Lichtner P, et al. (2009). “The transcription factor PITX3 is associated with sporadic Parkinson’s disease”. Neurobiol. Aging. 30 (5): 731–8. doi:10.1016/j.neurobiolaging.2007.08.014. PMID 17905480.
- Finsterer J, Stöllberger C (2003). “LMX1B 17-bp deletion and A3243G mtDNA transition in a previously described patient”. Eur. Neurol. 49 (3): 186–7. doi:10.1159/000069078. PMID 12646768.
- Marini M, Bongers EM, Cusano R, et al. (2003). “Confirmation of CLIM2/LMX1B interaction by yeast two-hybrid screening and analysis of its involvement in nail-patella syndrome”. Int. J. Mol. Med. 12 (1): 79–82. doi:10.3892/ijmm.12.1.79. PMID 12792813.
- Balci S, Engiz O (2007). “Co-occurrence of familial Mediterranean fever (FMF) heterozygote mutation and nail-patella syndrome (NPS) in 3 members of a family with LMX1B mutation analysis”. Genet. Couns. 18 (2): 259–62. PMID 17710881.
External links
External links
- GeneReviews/NIH/NCBI/UW entry on Nail-Patella Syndrome
- LIM+homeobox+transcription+factor+1+beta at the US National Library of Medicine Medical Subject Headings (MeSH)